Outreach and Reminders to Improve Human Papillomavirus Vaccination in an Integrated Primary Care System

Clinical Pediatrics
Nora B HenriksonAnnika M Hofstetter

Abstract

This study evaluated the impact of health system-based outreach and reminders on human papillomavirus (HPV) vaccine series initiation and completion. Parents of 10 to 12 year olds (n = 1805) were randomized to receive either (1) an outreach letter and brochure recommending HPV vaccination followed by automated HPV vaccine reminders or (2) usual care. We interviewed a subset of 50 parents to assess program acceptability. Outcomes were HPV vaccine initiation during the study period and on-time series completion. Rates of HPV vaccine initiation during the study period (July 2015 to August 2016) were similar between the intervention and control groups, but initiation within 120 days of randomization was higher in the intervention group (23.6% and 18.8%, P = .04) as was completion during the study period (10.3% vs 6.8%, P = .04). Reminders for doses 2 and 3 did not affect completion. The program was acceptable to parents. This study provides evidence that health system-based outreach and reminders can improve HPV vaccination.

References

Feb 9, 2011·Vaccine·Elyse Olshen KharbandaVaughn I Rickert
Mar 7, 2012·American Journal of Public Health·Melissa S StockwellVaughn I Rickert
Mar 26, 2013·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Brenda CassidyElizabeth A Schlenk
Feb 18, 2014·Vaccine·Annika M HofstetterKaren Soren
Apr 23, 2014·The Journal of School Health·Jennifer L MossNoel T Brewer
Dec 3, 2014·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Chun ChaoLanfang Xu
Apr 13, 2015·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Cynthia M RandPeter G Szilagyi
Dec 3, 2015·American Journal of Obstetrics and Gynecology·Sara E MazzoniSean T O'Leary
Jan 27, 2016·Human Vaccines & Immunotherapeutics·Rebecca B PerkinsNatalie Pierre-Joseph
Feb 4, 2016·Human Vaccines & Immunotherapeutics·Melissa B Gilkey, Annie-Laurie McRee
Feb 28, 2016·Pediatrics·Allison KempeMatthew F Daley
Jul 9, 2016·MMWR. Morbidity and Mortality Weekly Report·Laura J ViensMona Saraiya
Jul 15, 2016·Preventive Medicine Reports·Nora B HenriksonAnnie-Laurie McRee
Feb 18, 2017·Patient Education and Counseling·Diane B FrancisTamera Coyne-Beasley
May 4, 2017·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Huong Q McLeanEdward A Belongia
Aug 25, 2017·MMWR. Morbidity and Mortality Weekly Report·Tanja Y WalkerShannon Stokley

❮ Previous
Next ❯

Software Mentioned

IVR
SAS

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.